Steering group member for the European school of Oncology working party on the access to innovation in cancer treatment. Faculty for the annual ECCO meeting and ESMO-Barcelona – speaking on innovation and value based medicine.
Prof Cornes was part of the team that developed and presented evidence to the Oncology advisory drugs committee of the FDA for the first successfully approved US biosimilar. He is faculty for the CME program of the European Association of Hospital Pharmacists for 2016, 2017 & 2018. He is also a core lecturer for the European School of Oncology.
Professor Andrew Protheroe is an Associate Professor of Medical Oncologist within the University of Oxford Department of Oncology at the Oxford Cancer and Hematology Centre. He has specialized in Urological Oncology at Oxford since 2001. He qualified from St Thomas’s Hospital in London and after general medical training in London, trained in Oncology at St James’s University Hospital in Leeds. His PhD was in tumor immunology (immune reconstitution following high dose chemotherapy) and the research was at Leeds and at the National Cancer Institute in Amsterdam.
László Gulácsi works as an acting Vice Rector for Research, and a professor at Health Economics Research Centre, University Research and Innovation Center, Óbuda University of Budapest, Hungary. He also works as a professor at Advanced Study Center, Corvinus University of Budapest. He is a member of the Standing Committee of Pharmacy, Hungarian Academy of Science.
He is a member of the Editorial Board of the European Journal of Health Economics (EJHE), the Value in Health Regional Issues (ViHRI) Editorial Advisory Board, the Editorial Board of the Hungarian Medical Journal, and the Society and Economy, Health Academy, University of Pécs, Clinical Dermatology Open Access Journal, Associate Editorial and peer reviewer of Dove Medical press journals.
He is the past President of the Health and Health Care Economics Section of the Hungarian Economics Association.
To date he (co)authored 358 scientific articles in peer reviewed journals, published 12 books, 66 book chapters on health economics, public health, health technology assessment, health policy and quality improvement.
Steven Krauss, PhD, is a Professor with the Dept. of Professional Development and Continuing Education, Faculty of Educational Studies, and a Research Associate with the Institute for Social Science Studies (IPSAS).
His teaching and scholarship centre around youth development, human resource development and qualitative research methods. His current research and scholarship focus on the role of youth-adult partnerships within the field of youth development and education.
His work has been published widely in both local and international academic journals, books and book chapters.
President of hematology college of ” ile de France”. Hematologist, PH in “Pitié-SalpetrièreHaospital”, APHP, Sorbonne Université. President of Hospital life committee.
Vice-President of the Establishment Medical Committee.
Biography
Le Dr Sylvain Choquet est hématologue à la Pitié-Salpêtrière en hématologie clinique.
Normalien, le Dr Choquet est un spécialiste de renommée internationale dans le domaine des lymphoproliférations post transplantation, il est également spécialiste des lymphomes du patient porteur du VIH et des lymphomes du système nerveux central.
Le Dr Choquet dirige le registre national des hémopathies lymphoïdes familiales.
Sociétés savantes
Le Dr Choquet est :